TITLE

Mixed Glycoprotein B Genotypes of Cytomegalovirus and Immunosuppression

AUTHOR(S)
Crumpacker, Clyde S.
PUB. DATE
July 2004
SOURCE
Clinical Infectious Diseases;7/15/2004, Vol. 39 Issue 2, p162
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
This article presents a commentary note on an article discussing mixed cytomegalovirus (CMV) glycoprotein B genotypes in immunocompromised patients. It is reported that CMV infection remains the most significant infection affecting the outcome of solid-organ transplantation or hematopoietic stem cell transplantation. The remarkable achievements associated with antiviral therapy for CMV infection have led to the development of 2 new challenges in transplant recipients: the new syndrome of late-onset CMV disease, and infection with drug-resistant strains of CMV. But, late-onset CMV disease syndrome is analyzed to be the result of antiviral therapy delaying but not preventing the onset of CMV disease in patients who are predisposed to develop it. Antiviral prophylaxis has also been attributed to improvement in events indirectly associated with CMV infection, such as decreases in the rate of graft rejection and improvements in the use of in-patient medical resources.
ACCESSION #
13726776

 

Related Articles

  • Donor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell Transplantation. Kongtim, Piyanuch; Cao, Kai; Ciurea, Stefan O. // Advances in Hematology;1/24/2016, p1 

    Outcomes of allogeneic hematopoietic stem cell transplantation (AHSCT) using HLA-half matched related donors (haploidentical) have recently improved due to better control of alloreactive reactions in both graft-versus-host and host-versus-graft directions. The recognition of the role of humoral...

  • Impact of Inflammatory Cytokine Gene Polymorphisms on Developing Acute Graft-versus-Host Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Masetti, Riccardo; Zama, Daniele; Urbini, Milena; Astolfi, Annalisa; Libri, Virginia; Vendemini, Francesca; Morello, William; Rondelli, Roberto; Prete, Arcangelo; Pession, Andrea // Journal of Immunology Research;4/20/2015, Vol. 2015, p1 

    Single nucleotide polymorphisms (SNPs) in gene encoding pro- and anti-inflammatory factors have been associated with the occurrence of aGvHD. We retrospectively tested a wide panel of 38 polymorphisms in 19 immunoregulatory genes, aiming to first establish, in a pediatric HSCT setting, which...

  • Integration of humoral and cellular HLA-specific immune responses in cord blood allograft rejection. Hanajiri, R; Murata, M; Sugimoto, K; Murase, M; Sakemura, R; Goto, T; Watanabe, K; Imahashi, N; Terakura, S; Ohashi, H; Akatsuka, Y; Kurahashi, S; Miyamura, K; Kiyoi, H; Nishida, T; Naoe, T // Bone Marrow Transplantation;Sep2015, Vol. 50 Issue 9, p1187 

    In allo-stem cell transplantation (SCT), it is unclear whether donor-specific anti-HLA Abs (DSAs) can actually mediate graft rejection or if they are simply surrogate markers for the cellular immunity that causes graft rejection. Here, we first analyzed a case of cord blood allograft rejection...

  • Influence of GST gene polymorphisms on busulfan pharmacokinetics in children. Ansari, M.; Lauzon-Joset, J-F.; Vachon, M-F.; Duval, M.; Théoret, Y.; Champagne, M. A.; Krajinovic, M. // Bone Marrow Transplantation;Feb2010, Vol. 45 Issue 2, p261 

    Busulfan (BU) is a key compound in conditioning myeloablative regimens for children undergoing hematopoietic stem cell transplantation (HSCT). There are wide interindividual differences in BU pharmacokinetics, which increase the risk of veno-occlusive disease, graft rejection and disease...

  • Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation. McCune, J.S.; Gooley, T.; Gibbs, J.P.; Sanders, J.E.; Petersdorf, E.W.; Appelbaum, F.R.; Anasetti, C.; Risler, L.; Sultan, D.; Slattery, J.T. // Bone Marrow Transplantation;8/1/2002, Vol. 30 Issue 3, p167 

    Analyzes the relationship between busulfan average steady-state plasma concentration and graft rejection in children receiving busulfan/cyclophosphamide preparative regimens prior to hematopoietic stem cell transplantation. Dosing and pharmacokinetic methods for oral busulfan; Assessment of...

  • Haploidentical Hematopoietic Stem-Cell Transplantation in Adults. Alshemmari, Salem; Ameen, Reem; Gaziev, Javid // Bone Marrow Research;2011, p1 

    Haploidentical hematopoietic stem-cell transplantation is an alternative transplant strategy for patients without an HLA-matched donor. Still, only half of patients who might benefit from transplantation are able to find an HLA-matched related or unrelated donor. Haploidentical donor is readily...

  • Genetic Background of Immune Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children. Skoczen, Szymon; Bik-Multanowski, Miroslaw; Pietrzyk, Jacek J.; Grabowska, Agnieszka; Fijorek, Kamil; Strojny, Wojciech; Klus-Kwiecinska, Kinga; Balwierz, Walentyna; Siedlar, Maciej // Stem Cells International;1/6/2016, p1 

    Immune reactions are among the most serious complications observed after hematopoietic stem cell transplantation (HSCT) in children. Microarray technique allows for simultaneous assessment of expression of nearly all human genes. The objective of the study was to compare the whole genome...

  • The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors. Koclega, Anna; Markiewicz, Miroslaw; Siekiera, Urszula; Dobrowolska, Alicja; Sylwia, Mizia; Dzierzak-Mietla, Monika; Zielinska, Patrycja; Kruszelnicka, Malgorzata Sobczyk; Lange, Andrzej; Kyrcz-Krzemien, Slawomira // Bone Marrow Research;2012, p1 

    Although anti-human leukocyte antigen antibodies (anti-HLA Abs) are important factors responsible for graft rejection in solid organ transplantation and play a role in post-transfusion complications, their role in allogeneic hematopoietic stem cell transplantation (allo-HSCT) has not been...

  • Donor CD31 genotype and its association with acute graft-versus-host disease in HLA identical sibling stem cell transplantation. Goodman, R. S.; Ewing, J.; Evans, P. C.; Craig, J.; Poulton, K.; Dyer, P. A.; Marcus, R. E.; Taylor, C. J. // Bone Marrow Transplantation;Jul2005, Vol. 36 Issue 2, p151 

    Summary:CD31 gene polymorphisms are implicated in the pathogenesis of graft-versus-host disease (GvHD) following haematopoietic stem cell transplantation (HST). We investigated the influence of CD31 genotype on the incidence of GvHD following HST from an human leukocyte antigen (HLA)-identical...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics